Lobucavir
Lobucavir (BMS-180194; SQ 34514), a nucleoside analogue, is an antiviral agent. Lobucavir shows a broad spectrum of activity against HBV, HIV/AIDS, and α, β, and γ herpes viruses including CMV, herpes-simplex, varicella-zoster, and Epstein-Barr virus[1].
Product Specifications
CAS Number
127759-89-1
Product Name Alternative
BMS-180194; SQ 34514
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
CMV; EBV; HBV; HIV; Nucleoside Antimetabolite/Analog
Type
Reference compound
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/lobucavir.html
Smiles
OC[C@H]1[C@@H](C[C@@H]1CO)N2C3=C(C(NC(N)=N3)=O)N=C2
Molecular Formula
C11H15N5O3
Molecular Weight
265.27
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
[1]Jochen Woicke, et al. Lobucavir-induced proliferative changes in mice. Exp Toxicol Pathol. 2007 Nov;59 (3-4) :197-204.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD22 / BL-CAM (B-Cell Marker) (RFB4), CF405S conjugate, 0.1mg/mL
